Pertussis Completed Phase 4 Trials for Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

DBCOND0014696 (Pertussis)Completed4 IdentifierTitlePurposeDrugs
NCT01698346Pertussis (Tdap) Vaccination in PregnancyPrevention
NCT02408926Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in ThailandPrevention
NCT02526394Pertussis and Meningitis C Concomitant Vaccination in AdolescentsTreatment
NCT00635128Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio VaccinePrevention
NCT00319553Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®Prevention
NCT00514059Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccinePrevention
NCT00802867Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™Prevention
NCT01457547Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination CoursePrevention
NCT01629589Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsPrevention
NCT01659996Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgePrevention